🕵️ Evolent Health, Inc. ($EVH)
SEC insider & ownership activity, last 12 months · CIK 1628908 · every row links its SEC filing
Over the last 12 months insiders sold $329K against $38K of open-market buying. McCarthy Daniel Joseph sold $329K through a 10b5-1 trading plan in 1 lots (Aug). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $38K (1 lots) · 1 seller, $329K (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| McCarthy Daniel Joseph | 0 | – | 1 | $329K | Aug 26, 2026 |
| Brendan B. Springstubb | 1 | $38K | 0 | – | Nov 18, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Cadian Capital Management, LP | 9.3% | 13G | May 15, 2025 | filing ↗ | |
| Cadian Capital Management GP, LLC | 9.3% | 13G | May 15, 2025 | filing ↗ | |
| Eric Bannasch | 9.3% | 13G | May 15, 2025 | filing ↗ | |
| Wellington Management Company LLP | 8.8% | 13G | Feb 10, 2025 | filing ↗ | |
| BlackRock Portfolio Management LLC | 5.5% | Class A | 13G | Jul 17, 2026 | filing ↗ |
| Rubicon OP GP II LP | 5.2% | 13G | Nov 14, 2025 | filing ↗ | |
| Rubicon OP GP II LLC | 5.2% | 13G | Nov 14, 2025 | filing ↗ | |
| Rubicon Founders LLC | 5.2% | 13G | Nov 14, 2025 | filing ↗ | |
| Boehler Adam | 5.2% | 13G | Nov 14, 2025 | filing ↗ | |
| Morgan Stanley | exited | Class A | 13G | Sep 8, 2026 | filing ↗ |
| Morgan Stanley Capital Services LLC | exited | Class A | 13G | Sep 8, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Daniel McCarthy | $327K | Aug 26, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 6, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 4, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Earnings (2.02) | Feb 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 24, 2026 | filing ↗ |
| Other events (8.01) | Dec 5, 2025 | filing ↗ |
| Officer/director changes (5.02) | Dec 1, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 1, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Officer/director changes (5.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 23, 2025 | filing ↗ |
| Other events (8.01) | Sep 23, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 23, 2025 | filing ↗ |